clotrimazole has been researched along with Injuries, Radiation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Sayed, S | 2 |
Nabid, A | 1 |
Shelley, W | 1 |
Hay, J | 2 |
Balogh, J | 1 |
Gelinas, M | 1 |
MacKenzie, R | 1 |
Read, N | 1 |
Berthelet, E | 1 |
Lau, H | 1 |
Epstein, J | 2 |
Delvecchio, P | 1 |
Ganguly, PK | 1 |
Wong, F | 1 |
Burns, P | 2 |
Tu, D | 1 |
Pater, J | 1 |
Minish, E | 1 |
Laukkanen, E | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Randomized Evaluation of a Phytopharmaceutical in Prevention of Severe Oral Mucositis in Patients Receiving Radiotherapy for Oral Cavity, Oropharynx, Hypopharynx, or Cavum Cancer[NCT01066741] | Phase 3 | 78 participants (Actual) | Interventional | 2009-05-31 | Terminated (stopped due to insufficient recruitment, the planed sample size appears not achievable) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for clotrimazole and Injuries, Radiation
Article | Year |
---|---|
Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis sc
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Clotrimazole; | 2002 |
A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy.
Topics: Administration, Oral; Adult; Aged; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Female; Follo | 2002 |